Tuesday 7th February I 14:00 - 18:00
Johannesburg room I Z1.D10
Session summary
Healthcare professionals are encouraged to join this clinical and scientific session for updates on the use of Point of Care diagnostics for COVID-19 and Influenza testing in decentralized settings. Investigators and clinical experts will share their research and practical experience with point of care testing. The availability of timely results and its impact on patient management and antimicrobial resistance prevention.
Learning objectives
Session summary
Gaps in diagnostics and monitoring treatment of HIV are perpetuating the epidemic. While progress has been made, barriers to HIV testing remain with failure to identify new cases, missing diagnostic in the acute phase and Lost of follow up, which are impacting the achievement of UNAID's 95/95/95 goals. Increasing knowledge of HIV status is a must. Early detection of individuals in the highly infectious acute phase is a key factor in reducing transmission. A reduction in lost to follow up patients by providing results immediately is a key element in the fight against AIDS. Join this program for insights on rapid, accessible, and accurate testing methods.
Learning objectives
Session summary
Healthcare professionals are encouraged to join this Market Access session looking into policy adoption for Point of Care. Our key speakers will share recent successful Point of Care policy change adopted in UAE for respiratory diseases, and the strategy that can be used to implement Point of Care test and treat. The session will focus on the increasing burden of AMR in the Middle East region and how Point of Care can reduce this burden.
Learning objectives
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 113,000 colleagues serve people in more than 160 countries.